Position in ZYME
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,100,282
-$2,079,342 QoQ
Shares Held
118,603
-42.7% QoQ
Ownership
0.167%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#47
of 202 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $623,499,718 across 77 Biotechnology names. ZYME ranks #31 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
175,291 | $109,300,950 | |
| 2 | INCY |
Incyte Corp
|
881,889 | $99,970,937 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
664,031 | $40,080,911 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
337,461 | $39,506,559 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
490,724 | $27,878,030 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
104,935 | $25,286,186 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
1,291,182 | $24,158,015 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
572,538 | $21,304,138 |
All Filings in ZYME
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,100,282 | 118,603 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $5,179,624 | 206,854 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,062,586 | 78,336 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,811,709 | 106,072 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $421,165 | 33,559 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $3,137,908 | 214,338 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,265,868 | 100,866 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||